ArticleFrontiers in pharmacology2026

Effects of inclisiran therapy on metabolomic and lipoproteomic profiles in dyslipidemic patients.

Jacopo Patrussi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.